Clinical Utility of Change in Nonalcoholic Fatty Liver Disease Activity Score and Change in Fibrosis in NAFLD

Document Details

Document Type
Pub Defense Publication
Publication Date
Dec 01, 2021
Source ID
10.1016/j.cgh.2020.11.005

Entities

People

  • Aed Qas Yonan
  • Cynthia Behling
  • Jinho Jung
  • Mark A. Valasek
  • Nagambika Munaganuru
  • Nobuharu Tamaki
  • Richele Bettencourt
  • Rohit Loomba
  • Veeral H Ajmera

Organizations

  • Allergan, Inc.
  • Arrowhead Research
  • AstraZeneca
  • Boehringer Ingelheim (United States)
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • Gilead Sciences
  • National Heart, Lung, and Blood Institute
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institute of Environmental Health Sciences
  • National Institutes of Health
  • Siemens (United States)
  • Uehara Memorial Foundation
  • United States Department of Defense